Researchers are demanding answers from the makers of Pradaxa blood thinner after accusations that the drug's manufacturers withheld information about some of its dangerous side effects.
Pradaxa is marketed as a blood thinner with the added benefit of stroke prevention that doesn't require frequent blood tests like similar medicines. Any blood thinner carries a risk of increased bleeding rates, but a recent Medicare study found that internal bleeding specific to the stomach and intestines was also common among Pradaxa users.
Furthermore, 40% of patients whose bleeding was linked to their use of Pradaxa could have avoided complications with regular blood monitoring, the study claims. Doctors are asserting that if they could have kept track of patient reactions to the drug with tests, they may have been able to lower their patients' dosage before any serious bleeding occurred. An internal investigation of Boehringer Ingelheim, the makers of Pradaxa, revealed that scientists knew of these risks.
Boehringer Ingelheim is disputing the findings, claiming that every risk was published when they gained the approval of the Food and Drug Administration. As more research comes out, both parties urge patients not to discontinue use of the medicine, but rather speak to their doctors about what risks are involved in this treatment.
Too often, medicines intended to help us can cause pain and suffering. If you or someone you care about was hurt by a harmful drug, you may have a case.
Contact our law firm for a free legal consultation. There's no obligation to use our services, and there's never a fee unless we get money for you. Talk to us today to see what we can do for you.